Cargando…

Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats

Xanthurenic acid 8-o-β-d-glucoside is an endogenous derivative of tryptophan metabolism, isolated from urine of patients with chronic renal disease. This compound was suggested previously to act as a natriuretic hormone based on its ability to block short circuit currents in a frog skin assay and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Aaron, Okun-Gurevich, Marina, Ovcharenko, Elena, Goltsman, Ilia, Karram, Tony, Cain, Cristopher, Abassi, Zaid, Winaver, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871470/
https://www.ncbi.nlm.nih.gov/pubmed/24400157
http://dx.doi.org/10.1002/phy2.155
_version_ 1782296817261608960
author Hoffman, Aaron
Okun-Gurevich, Marina
Ovcharenko, Elena
Goltsman, Ilia
Karram, Tony
Cain, Cristopher
Abassi, Zaid
Winaver, Joseph
author_facet Hoffman, Aaron
Okun-Gurevich, Marina
Ovcharenko, Elena
Goltsman, Ilia
Karram, Tony
Cain, Cristopher
Abassi, Zaid
Winaver, Joseph
author_sort Hoffman, Aaron
collection PubMed
description Xanthurenic acid 8-o-β-d-glucoside is an endogenous derivative of tryptophan metabolism, isolated from urine of patients with chronic renal disease. This compound was suggested previously to act as a natriuretic hormone based on its ability to block short circuit currents in a frog skin assay and to induce a sustained natriuresis when injected into rats (C. D. Cain et al., Proc. Natl. Acad. Sci. USA 2007: 17873–17878). The present communication describes the effects of the compound on renal clearance and hemodynamic parameters in male Sprague–Dawley rats maintained on a normal salt (0.4–0.5%) diet. Intravenous administration of synthetic xanthurenic acid 8-o-β-d-glucoside in two consecutive incremental doses (6.3 and 31.5 nmol) resulted in a significant increase (P < 0.05), in urine flow (43.91 ± 6.31 μL/min vs. 10.54 ± 2.21 μL/min), absolute rate of sodium excretion (3.99 ± 0.95 μEq/min vs. 1.15 ± μEq/min), and percentage sodium excretion (1.63 ± 0.46% vs. 0.37 ± 0.12%, peak response vs. baseline, respectively). The natriuretic/diuretic effect was associated also with a significant increase in potassium excretion. These effects were not related to changes in renal hemodynamics or in arterial blood pressure. Pretreatment with the sodium channel blocker, amiloride, completely abolished the natriuretic and kaluretic actions of the compound. Administration of the xanthurenic acid derivative caused a dose-related increase in urinary nitrite/nitrate excretion. Moreover, under chronic nitric oxide blockade by l-NG-Nitro-Arginine-Methyl-Esther (l-NAME) sodium excretion was similar in rats treated or untreated with the compound. Our data demonstrate that xanthurenic acid 8-o-β-d-glucoside has significant diuretic/natriuretic and kaluretic properties. An intact amiloride-sensitive sodium channel is required for the renal effects of the compound. The data further suggest that the natriuretic effect is mediated in part by a nitric oxide-dependent mechanism.
format Online
Article
Text
id pubmed-3871470
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38714702014-01-07 Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats Hoffman, Aaron Okun-Gurevich, Marina Ovcharenko, Elena Goltsman, Ilia Karram, Tony Cain, Cristopher Abassi, Zaid Winaver, Joseph Physiol Rep Original Research Xanthurenic acid 8-o-β-d-glucoside is an endogenous derivative of tryptophan metabolism, isolated from urine of patients with chronic renal disease. This compound was suggested previously to act as a natriuretic hormone based on its ability to block short circuit currents in a frog skin assay and to induce a sustained natriuresis when injected into rats (C. D. Cain et al., Proc. Natl. Acad. Sci. USA 2007: 17873–17878). The present communication describes the effects of the compound on renal clearance and hemodynamic parameters in male Sprague–Dawley rats maintained on a normal salt (0.4–0.5%) diet. Intravenous administration of synthetic xanthurenic acid 8-o-β-d-glucoside in two consecutive incremental doses (6.3 and 31.5 nmol) resulted in a significant increase (P < 0.05), in urine flow (43.91 ± 6.31 μL/min vs. 10.54 ± 2.21 μL/min), absolute rate of sodium excretion (3.99 ± 0.95 μEq/min vs. 1.15 ± μEq/min), and percentage sodium excretion (1.63 ± 0.46% vs. 0.37 ± 0.12%, peak response vs. baseline, respectively). The natriuretic/diuretic effect was associated also with a significant increase in potassium excretion. These effects were not related to changes in renal hemodynamics or in arterial blood pressure. Pretreatment with the sodium channel blocker, amiloride, completely abolished the natriuretic and kaluretic actions of the compound. Administration of the xanthurenic acid derivative caused a dose-related increase in urinary nitrite/nitrate excretion. Moreover, under chronic nitric oxide blockade by l-NG-Nitro-Arginine-Methyl-Esther (l-NAME) sodium excretion was similar in rats treated or untreated with the compound. Our data demonstrate that xanthurenic acid 8-o-β-d-glucoside has significant diuretic/natriuretic and kaluretic properties. An intact amiloride-sensitive sodium channel is required for the renal effects of the compound. The data further suggest that the natriuretic effect is mediated in part by a nitric oxide-dependent mechanism. Blackwell Publishing Ltd 2013-11 2013-11-13 /pmc/articles/PMC3871470/ /pubmed/24400157 http://dx.doi.org/10.1002/phy2.155 Text en © 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Research
Hoffman, Aaron
Okun-Gurevich, Marina
Ovcharenko, Elena
Goltsman, Ilia
Karram, Tony
Cain, Cristopher
Abassi, Zaid
Winaver, Joseph
Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title_full Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title_fullStr Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title_full_unstemmed Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title_short Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
title_sort renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871470/
https://www.ncbi.nlm.nih.gov/pubmed/24400157
http://dx.doi.org/10.1002/phy2.155
work_keys_str_mv AT hoffmanaaron renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT okungurevichmarina renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT ovcharenkoelena renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT goltsmanilia renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT karramtony renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT caincristopher renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT abassizaid renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats
AT winaverjoseph renaleffectsofanovelendogenousnatriureticagentxanthurenicacid8obdglucosideinrats